title: Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters.
authors.affiliation: Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
authors.forename: Hiltrud
authors.initials: H
authors.lastname: Brauch
authors.forename: Werner
authors.initials: W
authors.lastname: Schroth
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Goetz
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Mürdter
authors.forename: Stefan
authors.initials: S
authors.lastname: Winter
authors.forename: James N
authors.initials: JN
authors.lastname: Ingle
authors.forename: Matthias
authors.initials: M
authors.lastname: Schwab
authors.forename: Michel
authors.initials: M
authors.lastname: Eichelbaum
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology* / Q000235:genetics; D002298:Cardenolides / Q000493:pharmacokinetics; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D005260:Female; D006801:Humans; D011110:Polymorphism, Genetic; D017698:Postmenopause / Q000235:genetics* / Q000378:metabolism; D012503:Saponins / Q000493:pharmacokinetics; D013629:Tamoxifen / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D002298:Cardenolides; D012503:Saponins; C034504:digoxin-like factors; D013629:Tamoxifen; C016601:afimoxifene; D019389:Cytochrome P-450 CYP2D6